Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» NKTR-102
NKTR-102
Breast cancer drug, key to Nektar growth plans, fails clinical trial
Breast cancer drug, key to Nektar growth plans, fails clinical trial
Bizjournals.com
Nektar
NKTR-102
breast cancer
Flag link:
Nektar reports positive preclinical data for two oncology programs
Nektar reports positive preclinical data for two oncology programs
The Fly on the Wall
Nektar
NKTR-102
NKTR-214
breast cancer
Flag link:
Nektar presents data from Phase l study of etirinotecan pegol
Nektar presents data from Phase l study of etirinotecan pegol
Yahoo/Fly on the Wall
Nektar
etirinotecan pegol
NKTR-102
advanced cancer
Flag link:
2014 Looking Like A Big Year For Nektar
2014 Looking Like A Big Year For Nektar
Seeking Alpha
Nektar
NKTR-118
NKTR-102
Flag link:
Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium
Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium
Yahoo/PR NewsWire
NKTR-102
Nektar
breast cancer
Flag link:
NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil
NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil
Yahoo/PR NewsWire
NKTR-102
ovarian cancer
Nektar
Flag link:
NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
NKTR-102
breast cancer
Nektar
topoisomerase I inhibitor
Flag link:
Nektar ovarian cancer drug gets FDA orphan status
Nektar ovarian cancer drug gets FDA orphan status
Bizjournals.com
orphan drugs
ovarian cancer
FDA
Nektar
NKTR-102
Flag link: